These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4175402)

  • 1. Arvin treatment for sickle-cell crisis.
    Gilles HM; Reid HA; Odutola A; Ransome-Kuti O; Ransome-Kuti S; Lesi F
    Lancet; 1968 Sep; 2(7567):542-3. PubMed ID: 4175402
    [No Abstract]   [Full Text] [Related]  

  • 2. Arvin treatment in sickle-cell crisis.
    Reid HA; Galles HM
    Trans R Soc Trop Med Hyg; 1969; 63(1):22-3. PubMed ID: 5789103
    [No Abstract]   [Full Text] [Related]  

  • 3. Ancrod in sickle-cell crisis.
    Mann JR; Deeble TJ; Breeze GR; Stuart J
    Lancet; 1972 Apr; 1(7757):934-7. PubMed ID: 4112100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pediatric management of sickle cell disease: experience at the Charles de Gaulle University Children's Hospital in Ouagadougou (Burkina Faso)].
    Yé D; Kouéta F; Dao L; Kaboret S; Sawadogo A
    Sante; 2008; 18(2):71-5. PubMed ID: 19188129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of Folic Acid Supplementation in Young Patients With Sickle Cell Anemia.
    Nguyen GT; Lewis A; Goldener C; Reed B; Dulman RY; Yang E
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):470-472. PubMed ID: 27571128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine levels in sickle cell disease and the need for folate supplementation.
    Schnog JB; van der Dijs FP; Brouwer DA; Duits AJ; Muskiet FD; Muskiet FA
    J Pediatr Hematol Oncol; 2000; 22(2):184-5; author reply 185-6. PubMed ID: 10779038
    [No Abstract]   [Full Text] [Related]  

  • 7. Ascorbic acid in sickle cell disease: results of a pilot therapeutic trial.
    Akinkugbe FM; Ette SI
    East Afr Med J; 1983 Oct; 60(10):683-7. PubMed ID: 6671426
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis.
    Richardson SG; Breeze GR; Stuart J
    J Clin Pathol; 1976 Oct; 29(10):890-3. PubMed ID: 977763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell anaemia: report of a therapeutic trial.
    Hendrickse RG; Barnes PM
    West Afr Med J; 1966 Apr; 15(2):55-64. PubMed ID: 5326524
    [No Abstract]   [Full Text] [Related]  

  • 10. Serial changes in coagulation and viscosity during sickle-cell crisis.
    Richardson SG; Matthews KB; Stuart J; Geddes AM; Wilcox RM
    Br J Haematol; 1979 Jan; 41(1):95-103. PubMed ID: 420740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation.
    Dhar M; Bellevue R; Carmel R
    N Engl J Med; 2003 May; 348(22):2204-7. PubMed ID: 12773647
    [No Abstract]   [Full Text] [Related]  

  • 12. Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients-a randomized placebo-controlled trial.
    Diop S; Soudré F; Seck M; Guèye YB; Diéye TN; Fall AO; Sall A; Thiam D; Diakhaté L
    Ann Hematol; 2011 Jan; 90(1):23-7. PubMed ID: 20694469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte folate does not accurately reflect folate status in sickle cell disease.
    Muskiet FA; van der Dijs FP; Fokkema MR; Muskiet FD
    Clin Chem; 2000 Dec; 46(12):2015-6. PubMed ID: 11106341
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of epsilon aminocaproic acid in sickle cell trait hematuria.
    Vega R; Shanberg AM; Malloy TR
    J Urol; 1971 Apr; 105(4):552-3. PubMed ID: 4997398
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of sickle cell anemia.
    Charache S
    Arch Intern Med; 1974 Apr; 133(4):698-705. PubMed ID: 4594401
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sickle cell disease in children. Value of hygergine in the treatment and prophylaxis of the crisis].
    Sanokho A; Martin L; Niang NK; Kuakuvi N
    Bull Soc Med Afr Noire Lang Fr; 1975; 20(1):83-9. PubMed ID: 820437
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombosis, megaloblastic anaemia, and sickle cell disease: a unified hypothesis.
    Ballas SK; Saidi P
    Br J Haematol; 1997 Mar; 96(4):879-80. PubMed ID: 9074441
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic defibrination by ancrod (Arvin).
    Reid HA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):209-15. PubMed ID: 4106010
    [No Abstract]   [Full Text] [Related]  

  • 19. Arvin treatment for sickle-cell crisis.
    Pitney WR
    Lancet; 1968 Sep; 2(7569):682. PubMed ID: 4175514
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of sickle-cell crisis by dexamethasone.
    Robinson B
    Lancet; 1979 May; 1(8125):1088. PubMed ID: 86814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.